Clinical Trial Update: Dupixent Study for Alternate Administration [Phase 4]

View source ↗

Summary

Phase 4 study evaluating alternate administration of dupilumab (Dupixent) for nasal polyps and sinusitis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Sinusitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Madigan Army Medical Center | Conditions: Nasal Polyps, Sinusitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING